IPO Boutique

Deciphera Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Deciphera Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Deciphera PharmaceuticalsDCPH -
NASDAQ
$15.00-$17.00 $17.00 $20.057.5 million9/28/2017
J.P. Morgan, Piper Jaffray
Co-Manager(s):
JMP Securities, Nomura
Health Care
Filing(s):

Filed 2017-09-01
Terms Added 2017-09-18



Deciphera Pharmaceuticals Quote & Chart - Click for current quote - DCPH

About Deciphera Pharmaceuticals (adapted from Deciphera Pharmaceuticals prospectus):
They are a clinical-stage biopharmaceutical company developing new drugs to improve the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response of many cancer therapies.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "DCPH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved